Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
151 results
  1. Niacin 
    https://medlineplus.gov/ency/article/002409.htm
    ... effects. Supplements in the form of nicotinamide or niacinamide do not appear to cause side effects.
  2. NLM Digital Collections - Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease : effectiveness and value 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020
    resource.nlm.nih.gov/101769581
    ... outcomes not of interest (e.g., red cell nicotinamide adenine dinucleotide redox potential). Of the 11 included references, 5 references related to a single Phase II ...
  3. Skin Cancer Prevention (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66059
    ... Poor. Systemic treatments to prevent skin cancer (NSAIDs, nicotinamide, isotretinoin, ... Weinstock MA, Thwin SS, Siegel JA, et al.: ...
  4. NLM Digital Collections - Manual of the Medical Department of the United States Navy 
    Publication: Washington : United States Government Printing Office, 1942
    resource.nlm.nih.gov/14321860R
    ... food. 3. Specific therapy: Nicotinic acid and its nicotinamide are specific. Appendix D Manual of the Medical Department Bureau Circular Letter Y Subject: Form A, Instructions. Reference: (a) Paragraph 3411 of this manual. (a) The ...
  5. NLM Digital Collections - Manual of the Medical Department of the United States Navy 
    Publication: Washington : U.S. Government Printing Office, 1943
    resource.nlm.nih.gov/14321870R
    ... food. 3. Specific therapy: Nicotinic acid and its nicotinamide are specific. Appendix D Manual of the Medical Department Bureau Circular Letter Y Subject: Form A, Instructions. Reference: (a) Paragraph 3411 of this manual. (a) The ...
  6. NLM Digital Collections - Atherogenesis 
    https://resource.nlm.nih.gov/101662437X198
    ... absent. However, the mechanism was well defined by references in my 1953 doctorate thesis. Folic acid is reduced to tetrahydrofolate by reduced nicotinamide adenine dinucleotide phosphate (NADH). The reductase enzyme, 5, ...
  7. NLM Digital Collections - Atherosclerosis 
    https://resource.nlm.nih.gov/101662437X846
    ... absent. However, the mechanism was well defined by references in my 1953 doctorate thesis. Folic acid is reduced to tetrahydrofolate by reduced nicotinamide adenine dinucleotide phosphate (NADH). The reductase enzyme, 5, ...
  8. NLM Digital Collections - Subcommittee on Medical Nutrition - reports 
    https://resource.nlm.nih.gov/101085500X318
    ... significance of this difference in the metabollsm of nicotinamide, or ... reference particularly to changes in nicotinic acld require- ments, | . ...
  9. Managing muscle-invasive bladder cancer - Bladder Cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK356308
    ... RT alone. Evidence statements Radiotherapy with carbogen and nicotinamide (RT+CON) versus radiotherapy alone Moderate quality evidence ... PubMed : 15878099 ] Hoskin PJ, et al. Carbogen and nicotinamide in locally advanced bladder cancer: early results of ...
  10. Managing muscle-invasive bladder cancer - Bladder Cancer - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK356289
    ... RT alone Evidence statements Radiotherapy with carbogen and nicotinamide (RT+CON) versus radiotherapy alone Moderate quality evidence ... 5-FU] f or carbogen in combination with nicotinamide g ) when giving radical radiotherapy (for example, 64 ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last